Affiliation:
1. Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency, Moscow, Russia
Abstract
The surgical treatment outcome in patients with pharmacoresistant epilepsy directly depends on the epileptic focus localization accuracy. Conventional diagnostic algorithms for patients with epilepsy involve starting with video EEG monitoring and magnetic resonance imaging. It is not possible to localize epileptogenic foci with the use of these techniques in a large segment of patients with pharmacoresistant epilepsy, or the test results are discordant. The review provides the analysis of literature data on the current possibilities of SPECT, PET and new hybrid PET-MRI technique when used for preoperative planning in patients with refractory epilepsy.
Publisher
Federal Medical Biological Agency
Subject
Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism,Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine,Cancer Research,Oncology,Health Informatics,Human Factors and Ergonomics,Health Information Management,Health Informatics,Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Health Informatics,Rehabilitation,Physical Therapy, Sports Therapy and Rehabilitation,Linguistics and Language,Communication,Language and Linguistics,Cultural Studies,Cardiology and Cardiovascular Medicine,Oncology